[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$spry Graphic](https://lunarcrush.com/gi/w:26/t:$spry.png) $spry

$SPRY's Neffy receives Japan approval, but faces criticism for actions against competitors. Investors are concerned about the company's actions, causing mixed sentiment.

### About $spry
A pharmaceutical company focused on allergy treatments, specifically epinephrine nasal spray.  

### Insights [#](/topic/$spry/insights)
- $spry engagements is up XX% from the previous week.
- $spry posts created is up XXXXX% from the previous week.

### Engagements: XXX [#](/topic/$spry/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$spry/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$spry/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXX +68%  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-05-27  
**1-Year Low**: X on 2025-10-19  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$spry/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$spry/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$spry/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-10-19  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$spry/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$spry/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$spry/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $spry in the last XX hours which is no change from in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-10-19  

The most influential creators that mention $spry in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$spry/100)
  
  
### Sentiment: XX% [#](/topic/$spry/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$spry/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$spry/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -X%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-26  

**Most Supportive Themes**
- **Approval and Expansion:** (35%) Positive sentiment surrounds the recent approval of $SPRY's Neffy in Japan and its potential for global expansion.
  
**Most Critical Themes**
- **Competition and Legal Challenges:** (60%)  Concerns and criticism arise from $SPRY's actions against competitors, particularly regarding the FDA petition to delay approval of Anaphylm.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XX       | XX% | XX      | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XX       | XX% | XX      | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $spry in the last XX hours

[CAVA Group, Inc. (CAVA)](/topic/$cava)
[Dawn Protocol (DAWN)](/topic/dawn-protocol)
[AeroVironment, Inc. (AVAV)](/topic/$avav)
[Primoris Services Corporation (PRIM)](/topic/$prim)
[Roku, Inc. (ROKU)](/topic/$roku)
[reAlpha Tech Corp. Common Stock (AIRE)](/topic/$aire)
[ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx)
[Morgan Stanley (MS)](/topic/morgan-stanley)
[Klaviyo, Inc. (KVYO)](/topic/$kvyo)
[Netskope, Inc. Class A Common Stock (NTSK)](/topic/$ntsk)

**Top topics mentioned**
In the posts about $spry in the last XX hours

[$aqst](/topic/$aqst), [stocks financial services](/topic/stocks-financial-services), [$evax](/topic/$evax), [$atxs](/topic/$atxs), [has been](/topic/has-been), [ars](/topic/ars), [exchanges](/topic/exchanges), [$atyr](/topic/$atyr), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$cava](/topic/$cava), [stocks technology](/topic/stocks-technology), [$urgn](/topic/$urgn), [$sndx](/topic/$sndx), [dawn protocol](/topic/dawn-protocol), [coins defi](/topic/coins-defi), [coins nft](/topic/coins-nft), [stocks communication services](/topic/stocks-communication-services), [stocks industrials](/topic/stocks-industrials), [$avav](/topic/$avav), [$prim](/topic/$prim), [$roku](/topic/$roku), [$atch](/topic/$atch), [$oris](/topic/$oris), [$aire](/topic/$aire), [$capr](/topic/$capr), [$ibrx](/topic/$ibrx), [morgan stanley](/topic/morgan-stanley), [$kvyo](/topic/$kvyo), [$ntsk](/topic/$ntsk), [$lnc](/topic/$lnc), [$lsta](/topic/$lsta), [$aard](/topic/$aard), [$imvt](/topic/$imvt), [$bhvn](/topic/$bhvn), [$phat](/topic/$phat), [$syre](/topic/$syre), [$tecx](/topic/$tecx), [$rytm](/topic/$rytm), [$ewtx](/topic/$ewtx), [stocks healthcare](/topic/stocks-healthcare), [$onc](/topic/$onc), [$incy](/topic/$incy), [nasdaq](/topic/nasdaq), [japan](/topic/japan), [$2784t](/topic/$2784t), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$oxy](/topic/$oxy), [$dkng](/topic/$dkng), [$mara](/topic/$mara), [$2b](/topic/$2b), [about to](/topic/about-to), [$vrca](/topic/$vrca), [$rigl](/topic/$rigl)

### Top Social Posts [#](/topic/$spry/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Amazing whenever these pods get liquidated you can really see just how consensus some of these shorts are like $IMVT $BHVN $PHAT $SYRE $TECX $SPRY lol"  
[X Link](https://x.com/MelvinRiskMgmt/status/1976354021066899930) [@MelvinRiskMgmt](/creator/x/MelvinRiskMgmt) 2025-10-09T18:28Z XXX followers, 4150 engagements


"$SPRY (and $AQST if approved) will save lives: "My X year old would be more likely to tell me he was having a reaction since he is terrified of needles." I've said many times: This is a REVOLUTIONARY time for food allergy treatment. $2B in sales about to shift to non-needle"  
[X Link](https://x.com/SmallCapKing2/status/1976302906610487323) [@SmallCapKing2](/creator/x/SmallCapKing2) 2025-10-09T15:05Z 3611 followers, 1111 engagements


"🧬 Biotech Stock News 10/8 Brought to you by Barb On the rise 📈 $EVAX XX% $ATXS X% $SPRY X% Under pressure 📉 $VRCA -X% $RIGL -X% $ESPR -XX% Catch the full breakdown in the latest video"  
[X Link](https://x.com/BiopharmIQ/status/1975981170727977148) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-08T17:46Z 27.4K followers, 3588 engagements


"📌 Biotech Stock News 10/08 @ Open $EVAX XX% Expands AI-Immunology Platform $ATXS X% Navenibart Ph3 Trial Initiation $SPRY X% Favorable Patent Decision on neffy $LSTA X% Global ADC License Agreement $AARD X% FDA Alignment on Protocol Amendment $TRVI X% Oral Presentation at CHEST 2025 $AQST X% Broadens Patent Estate for Anaphylm $HOWL X% Fast Track Designation for WTX-124 $OSTX -X% Participation in Fall 2025 Conferences $IVA -X% Presenting Multiple Abstracts at AASLD $ZBIO -X% License Agreement for Autoimmune Candidates $VRCA -X% New Data on VP-315 for BCC $RIGL -X% First Patient Enrolled in"  
[X Link](https://x.com/BiopharmIQ/status/1975950592465072591) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-08T15:45Z 27.4K followers, 7821 engagements